IFF Unveils PureStrong™: A New Probiotic Built from Canine Biology, Not Human Leftovers

The pet supplement market is undergoing a "precision wellness" shift as IFF (NYSE: IFF) launches PureStrong™, a novel probiotic that breaks the industry standard of repurposing human strains for dogs.

NEW YORK, USA – The days of simply shaking human-grade probiotic capsules into a dog’s bowl may soon be over. On April 2, 2026, global bioscience leader IFF introduced PureStrong™ , a probiotic ingredient designed specifically for the unique digestive biology of canines.

As the pet humanization trend drives the U.S. pet supplement market to a valuation of $3.2 billion, nearly half of pet owners are actively seeking probiotics for their dogs. However, IFF notes that most existing products rely on generic strains developed for humans or livestock. PureStrong™ aims to close this gap by utilizing a single, targeted strain of Limosilactobacillus reuteri sourced directly from the canine microbiome.

From the Human Gut to the Dog Bowl: A Scientific Shift

Veterinary experts have long warned that giving human probiotics to dogs can be ineffective—or even counterproductive. A dog’s gastrointestinal tract has a different pH level and bacterial balance than a human’s. According to veterinary professionals, using the wrong strains can lead to dysbiosis, severe diarrhea, or fail to survive the journey through the dog's gut.

IFF's new innovation addresses this biological mismatch. Because the L. reuteri strain in PureStrong™ originates from healthy dogs, it is naturally equipped to survive, attach, and compete in a canine's specific gut environment.

"This is pet-first science built specifically for canine biology," said Allyson Fish, Senior Vice President of health sciences for IFF, in the official announcement. "We are moving beyond trend-driven formulations toward precision wellness."

Market Context: The Rise of Species-Specific Pet Care

The launch comes at a critical inflection point in the animal health industry. Global market analysis projects the probiotics for pets sector to grow from $625.38 million in 2025 to $1.65 billion by 2032, a compound annual growth rate of nearly 15%.

This growth is fueled by the "humanization" of pets, where owners demand the same scientific rigor for their animals as they do for themselves. However, until now, the ingredient supply chain has lagged behind consumer demand.

Independent research supports IFF's approach. A 2024 study published by the National Institutes of Health (NIH) on canine-derived Limosilactobacillus reuteri confirmed that these strains exhibit high tolerance to gastric acid and bile salts—two major hurdles for probiotics—as well as significant antioxidant and antimicrobial activities.

Performance Data and Real-World Application

Beyond laboratory science, IFF provided clinical data demonstrating efficacy. In a controlled study involving healthy dogs undergoing an abrupt diet change (a common cause of stomach upset), those receiving PureStrong™ showed improved markers of digestive health.

Specifically, the dogs maintained better hydration and diet tolerance, resulting in firmer stools without constipation—a key metric for pet parents monitoring their animal's health.

The ingredient is designed to be versatile for manufacturers, fitting into powders, capsules, tablets, and sticks, allowing brands to create low-dose, highly targeted products without the complexity of multi-strain blends.

The Future of Pet Wellness

PureStrong™ is part of the larger HOWARU® Pet portfolio, which focuses exclusively on species-specific strains for both dogs and cats. For pet owners, the takeaway is clear: experts suggest choosing probiotics with identifiable strains, clear labeling, and, ideally, canine origin data.

As the bond between humans and their pets deepens, the industry is learning that better science for dogs doesn't start with human solutions—it starts with the dogs themselves.

About IFF
IFF (NYSE: IFF) is a global leader in food, beverage, health, biosciences, and scent. The company innovates to deliver essential solutions for a growing world.

Keywords

• Primary Keyword: Probiotic made specifically for dogs
• Secondary Keywords: Canine digestive health, Limosilactobacillus reuteri for dogs, pet supplement market 2026, IFF PureStrong, dog gut health.

###